Group-wide research and development activities
First written in FY2017-Q2. 18 of 26 entries say "Restated". Latest entry: FY2026.
45 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「As of the end of March 2026, the R&D Center had 53 staff, the Development Team of the New Business Development Department had 3, and the total staff comprised 56 people.」
Regarding its R&D structure, the company disclosed separate development departments for chemicals, synthetic resins and agriculture-related products. R&D expenses for the fiscal year were ¥806 million. - FY2026-H1RestatedAnnual report
「The amount spent on research and development activities across the Group during the interim consolidated accounting period was ¥321 million. There were no material changes in the status of the Group's research and development activities during the interim consolidated accounting period.」
The company disclosed ¥321 million in R&D expenses and reconfirmed that there were no material changes in its R&D activities. - FY2025-H1RestatedAnnual report
「The amount spent on research and development activities across the Group during the interim consolidated accounting period was ¥274 million. There were no material changes in the status of the Group's research and development activities during the interim consolidated accounting period.」
The company disclosed research and development expenses of ¥274 million and reconfirmed that there were no material changes in the status of its research and development activities. - FY2024AdvancedAnnual report
「As of the end of March 2024, the Research and Development Center comprised 58 staff, the Development Team of the New Business Development Department comprised 3 staff, and the total staff was 61.」
The company disclosed a total research and development workforce of 61 and established research and development functions for the agricultural-related business in addition to chemicals and synthetic resins. Research and development expenses were ¥551 million. - FY2024-Q3RestatedAnnual report
「The amount spent on research and development activities across the Group during the nine-month period ended was ¥420 million. There were no material changes in the status of the Group's research and development activities during the nine-month period ended.」
The company disclosed research and development expenses of ¥420 million and reconfirmed that there were no material changes in the status of its research and development activities. - FY2024-Q2RestatedAnnual report
「The amount spent on research and development activities across the Group during the six-month period ended was ¥282 million. There were no material changes in the status of the Group's research and development activities during the six-month period ended.」
The company disclosed research and development expenses of ¥282 million and reconfirmed that there were no material changes in the status of its research and development activities. - FY2024-Q1RestatedAnnual report
「The amount spent on research and development activities across the Group during the three-month period ended was ¥134 million. There were no material changes in the status of the Group's research and development activities during the three-month period ended.」
The company reported research and development expenses of ¥134 million and reconfirmed that there were no material changes in the status of these activities. - FY2023AdvancedAnnual report
「As of the end of March 2023, the Research and Development Center comprised 55 staff, the Development Team of the New Business Development Department comprised 4 staff, and the total staff was 59.」
The company expanded its research and development workforce to 59 and strengthened collaboration with the Research and Development Center through meetings and working groups within the sales division. Research and development expenses were ¥557 million. - FY2023-Q3RestatedAnnual report
「The amount spent on research and development activities across the Group during the nine-month period ended was ¥326 million. There were no material changes in the status of the Group's research and development activities during the nine-month period ended.」
The company reported research and development expenses of ¥326 million and reconfirmed that there were no material changes in the status of these activities. - FY2023-Q2RestatedAnnual report
「The amount spent on research and development activities across the Group during the six-month period ended was ¥219 million. There were no material changes in the status of the Group's research and development activities during the six-month period ended.」
The company reported research and development expenses of ¥219 million and reconfirmed that there were no material changes in the status of these activities. - FY2022AdvancedAnnual report
「As of the end of March 2022, the Research and Development Center comprised 49 staff, the Development Team of the New Business Development Department comprised 3 staff, and the total staff was 52.」
The company specified a total research and development workforce of 52 and worked to accelerate product development and strengthen collaboration through cross-departmental projects. Research and development expenses were ¥369 million. - FY2022-Q1RestatedAnnual report
「The amount spent on research and development activities across the Group during the three-month period ended was ¥88 million. There were no material changes in the status of the Group's research and development activities during the three-month period ended.」
The company reported research and development expenses of ¥88 million and reconfirmed that there were no material changes in the status of these activities. - FY2021AdvancedAnnual report
「Total research and development expenses for the consolidated fiscal year were ¥367 million. The status of research and development activities and research and development expenses by segment are as follows.」
Research and development expenses were ¥367 million. While maintaining a total workforce of 40 at the Research and Development Center and elsewhere, the company strengthened collaboration among customers, development teams and other internal departments and worked to accelerate product development. - FY2021-Q3RestatedAnnual report
「The amount spent on research and development activities across the Group during the nine-month period ended was ¥277 million. There were no material changes in the status of the Group's research and development activities during the nine-month period ended.」
The company reported research and development expenses of ¥277 million and reconfirmed that there were no material changes in the status of its research and development activities. - FY2021-Q2RestatedAnnual report
「The amount spent on research and development activities across the Group during the six-month period ended was ¥186 million. There were no material changes in the status of the Group's research and development activities during the six-month period ended.」
The company reported research and development expenses of ¥186 million and reconfirmed that there were no material changes in the status of these activities. - FY2021-Q1RestatedAnnual report
「The amount spent on research and development activities across the Group during the three-month period ended was ¥92 million. There were no material changes in the status of the Group's research and development activities during the three-month period ended.」
The company reported research and development expenses of ¥92 million and reconfirmed that there were no material changes in the status of its research and development activities. - FY2020AdvancedAnnual report
「This consolidated fiscal year marked the second year of full-scale research and development activities at the new Research and Development Center. As in the previous consolidated fiscal year, the center increased opportunities for development teams to hear customer requests directly and make proposals to customers that included direct technical explanations, enabling the company to pursue product development better aligned with customer needs and establishing a customer-focused product development structure.」
The company stated that, in the second year of full-scale activities at the new Research and Development Center, its customer-focused product development structure had become established. - FY2019AdvancedAnnual report
「As of the end of March 2019, the Research and Development Center comprised 38 staff, the Development Team of the Fine Chemicals Sales Department comprised 2 staff, and the total staff was 40.」
The company specified a total research and development workforce of 40, including the Research and Development Center, and stated that full-scale activities had begun at the new Research and Development Center. - FY2019-Q3RestatedAnnual report
「The amount spent on research and development activities across the Group during the nine-month period ended was ¥323 million. There were no material changes in the status of the Group's research and development activities during the nine-month period ended.」
The company reported research and development expenses of ¥323 million and stated that there were no material changes in the status of these activities. - FY2019-Q2RestatedAnnual report
「The amount spent on research and development activities across the Group during the six-month period ended was ¥217 million. There were no material changes in the status of the Group's research and development activities during the six-month period ended.」
The company reported research and development expenses of ¥217 million and stated that there were no material changes in the status of these activities. - FY2018RestatedAnnual report
「The status of research and development activities and research and development expenses by segment for the consolidated fiscal year are as follows.」
The company continues to disclose the Group's research and development activities and research and development expenses by segment. - FY2018-Q3RestatedAnnual report
「The amount spent on research and development activities across the Group during the nine-month period ended was ¥308 million. There were no material changes in the status of the Group's research and development activities during the nine-month period ended.」
The company reported research and development expenses of ¥308 million and stated that there were no material changes in the status of these activities. - FY2018-Q2RestatedAnnual report
「The amount spent on research and development activities across the Group during the six-month period ended was ¥195 million. There were no material changes in the status of the Group's research and development activities during the six-month period ended.」
The company reported research and development expenses of ¥195 million and stated that there were no material changes in the status of these activities. - FY2018-Q1RestatedAnnual report
「The amount spent on research and development activities across the Group during the three-month period ended was ¥93 million. There were no material changes in the status of the Group's research and development activities during the three-month period ended.」
The company reported research and development expenses of ¥93 million and stated that there were no material changes in the status of these activities. - FY2017-Q3RestatedAnnual report
「The amount spent on research and development activities across the Group during the nine-month period ended was ¥280 million. There were no material changes in the status of the Group's research and development activities during the nine-month period ended.」
The company reported research and development expenses of ¥280 million and stated that there were no material changes in the status of these activities. - FY2017-Q2First statedAnnual report
「The amount spent on research and development activities across the Group during the six-month period ended was ¥185 million. There were no material changes in the status of the Group's research and development activities during the six-month period ended.」
The company reported research and development expenses of ¥185 million for the year-to-date quarter and stated that there were no material changes in the status of these activities.